Alpelisib And Sacituzumab Govitecan For Treatment Of Breast Cancer
Clinical trial NCT05143229 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05143229
- Sponsor
- University of Kansas Medical Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2025-01-28
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.